These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 18178333

  • 41. Intestinal microflora and metabolic diseases.
    Serino M, Luche E, Chabo C, Amar J, Burcelin R.
    Diabetes Metab; 2009 Sep; 35(4):262-72. PubMed ID: 19419895
    [Abstract] [Full Text] [Related]

  • 42. Diet, obesity and diabetes: a current update.
    Walker CG, Zariwala MG, Holness MJ, Sugden MC.
    Clin Sci (Lond); 2007 Jan; 112(2):93-111. PubMed ID: 17155931
    [Abstract] [Full Text] [Related]

  • 43. Nutrition transition and its relationship to the development of obesity and related chronic diseases.
    Astrup A, Dyerberg J, Selleck M, Stender S.
    Obes Rev; 2008 Mar; 9 Suppl 1():48-52. PubMed ID: 18307699
    [Abstract] [Full Text] [Related]

  • 44. Phytosterols do not change susceptibility to obesity, insulin resistance, and diabetes induced by a high-fat diet in mice.
    Calpe-Berdiel L, Escolà-Gil JC, Rotllan N, Blanco-Vaca F.
    Metabolism; 2008 Nov; 57(11):1497-501. PubMed ID: 18940385
    [Abstract] [Full Text] [Related]

  • 45. Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice.
    Mercader J, Ribot J, Murano I, Feddersen S, Cinti S, Madsen L, Kristiansen K, Bonet ML, Palou A.
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E184-93. PubMed ID: 19417128
    [Abstract] [Full Text] [Related]

  • 46. Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity.
    Payne AN, Chassard C, Lacroix C.
    Obes Rev; 2012 Sep; 13(9):799-809. PubMed ID: 22686435
    [Abstract] [Full Text] [Related]

  • 47. Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?
    Gomes JM, Costa JA, Alfenas RC.
    Br J Nutr; 2015 Dec 14; 114(11):1756-65. PubMed ID: 26400630
    [Abstract] [Full Text] [Related]

  • 48. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.
    Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM.
    Diabetologia; 2007 Nov 14; 50(11):2374-83. PubMed ID: 17823788
    [Abstract] [Full Text] [Related]

  • 49. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice.
    Neyrinck AM, Possemiers S, Druart C, Van de Wiele T, De Backer F, Cani PD, Larondelle Y, Delzenne NM.
    PLoS One; 2011 Nov 14; 6(6):e20944. PubMed ID: 21695273
    [Abstract] [Full Text] [Related]

  • 50. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice.
    Karagiannides I, Abdou R, Tzortzopoulou A, Voshol PJ, Kypreos KE.
    FEBS J; 2008 Oct 14; 275(19):4796-809. PubMed ID: 18754772
    [Abstract] [Full Text] [Related]

  • 51. Energy balance, physical activity, and cancer risk.
    Fair AM, Montgomery K.
    Methods Mol Biol; 2009 Oct 14; 472():57-88. PubMed ID: 19107429
    [Abstract] [Full Text] [Related]

  • 52. Role of gut microbiota in the control of energy and carbohydrate metabolism.
    Venema K.
    Curr Opin Clin Nutr Metab Care; 2010 Jul 14; 13(4):432-8. PubMed ID: 20531179
    [Abstract] [Full Text] [Related]

  • 53. Time to insulin in type-2 diabetes: high hurdles or Santiago way?
    Rotella CM, Pala L.
    Acta Diabetol; 2008 Jun 14; 45(2):67-74. PubMed ID: 18408882
    [Abstract] [Full Text] [Related]

  • 54. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
    Caesar R, Fåk F, Bäckhed F.
    J Intern Med; 2010 Oct 14; 268(4):320-8. PubMed ID: 21050286
    [Abstract] [Full Text] [Related]

  • 55. Gut microbiota and the development of obesity.
    Boroni Moreira AP, Fiche Salles Teixeira T, do C Gouveia Peluzio M, de Cássia Gonçalves Alfenas R.
    Nutr Hosp; 2012 Oct 14; 27(5):1408-14. PubMed ID: 23478685
    [Abstract] [Full Text] [Related]

  • 56. Childhood obesity in Asian Indians: a burgeoning cause of insulin resistance, diabetes and sub-clinical inflammation.
    Bhardwaj S, Misra A, Khurana L, Gulati S, Shah P, Vikram NK.
    Asia Pac J Clin Nutr; 2008 Oct 14; 17 Suppl 1():172-5. PubMed ID: 18296330
    [Abstract] [Full Text] [Related]

  • 57. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L, Giorgio V, Alberelli MA, De Candia E, Gasbarrini A, Grieco A.
    Curr Cardiol Rep; 2015 Dec 14; 17(12):120. PubMed ID: 26497040
    [Abstract] [Full Text] [Related]

  • 58. The intestinal microbiota and obesity.
    Kallus SJ, Brandt LJ.
    J Clin Gastroenterol; 2012 Jan 14; 46(1):16-24. PubMed ID: 22064556
    [Abstract] [Full Text] [Related]

  • 59. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity.
    Kondo S, Xiao JZ, Satoh T, Odamaki T, Takahashi S, Sugahara H, Yaeshima T, Iwatsuki K, Kamei A, Abe K.
    Biosci Biotechnol Biochem; 2010 Jan 14; 74(8):1656-61. PubMed ID: 20699581
    [Abstract] [Full Text] [Related]

  • 60. The role of the gut microbiota in energy metabolism and metabolic disease.
    Cani PD, Delzenne NM.
    Curr Pharm Des; 2009 Jan 14; 15(13):1546-58. PubMed ID: 19442172
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.